US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist

114.480
-4.240-3.57%

Close Mar 3 16:00 ET

114.510
+0.030+0.03%

Pre 08:29 ET

11.41BMarket Cap34.80P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neurocrine Biosciences Q4 2024 Earnings Date

Currency：USDFeb 6, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	629.44M	627.70M	-1.74M
Miss Est.	+22.17%	+21.84%	-0.28%
EPS	1.51	1.00	-0.51
Miss Est.	+5.01%	-30.56%	-33.87%

Analyst Rating

Strong Buy

Mar 4, 2025

Neurocrine Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 652.537M	--
--	2025/Q1	-- / 604.761M	--
Feb 6, 2025	2024/Q4	627.700M / 629.435M	--
Oct 30, 2024	2024/Q3	622.100M / 602.780M	--
Aug 1, 2024	2024/Q2	590.200M / 546.595M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 652.537M--

--2025/Q1-- / 604.761M--

Feb 6, 20252024/Q4627.700M / 629.435M--

Oct 30, 20242024/Q3622.100M / 602.780M--

Aug 1, 20242024/Q2590.200M / 546.595M--

Unlock Free Earnings Estimates

Open Account

Neurocrine Biosciences Earnings Reports

Neurocrine Biosciences | 10-K: FY2024 Annual Report

Feb 10 16:56 ET

Neurocrine Biosciences | 8-K: Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2024 Financial Results and Provides Financial Expectations for 2025

Feb 6 16:10 ET

Neurocrine Biosciences | 10-Q: Q3 2024 Earnings Report

Oct 30, 2024 07:07 ET

Neurocrine Biosciences | 8-K: Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance

Oct 30, 2024 07:07 ET

Trending Stocks